Clinical Pearls Podcasts

MediCom Oncology Clinical Pearls Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting. For more tips and advice on best practices in patients, subscribe to our channel on iTunes.

What is the significance of minimal residual disease (MRD) as a surrogate marker in myeloma?

Shaji K. Kumar, MD

Clinical Pearls Podcasts published on April 7, 2021

Read More

How does adding a fourth drug to a myeloma treatment regimen affect the side effect burden?

Shaji K. Kumar, MD

Clinical Pearls Podcasts published on April 2, 2021

Read More

What is the rationale for utilizing quadruplet therapy for frontline treatment of myeloma?

Shaji K. Kumar, MD

Clinical Pearls Podcasts published on March 25, 2021

Read More

Targeting BCMA in Multiple Myeloma and the Approval of Belantamab Mafodotin

Sagar Lonial, MD, FACP

Clinical Pearls Podcasts published on October 30, 2020

Read More